Two new classifications for myeloid neoplasms were introduced in 2022: the International Consensus Classification (ICC) and the 5th edition WHO Classification (WHO-HAEM5). Both classifications build ...
Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results AML is a genetically heterogeneous disease, particularly in older patients. In patients older than 60 years, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results